ARS Pharmaceuticals, Inc.
SEC Filing List
SPRY CIK: 0001671858
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | Toppan Merrill/FA | 05/15/2026 | |||
| 10-Q | Quarterly report pursuant to Section 13 ... | Ars Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/15/2026 | |
| 8-K | Current report filing | Ars Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/13/2026 | |
| DEF 14A | Definitive proxy statements | Ars Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/29/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Ars Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/29/2026 | |
| ARS | Annual report to security holders | Ars Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/29/2026 | |
| SCHEDULE 13G/A | 04/27/2026 | ||||
| SCHEDULE 13G/A | Toppan Merrill/FA | 03/31/2026 | |||
| SCHEDULE 13G | Toppan Merrill/FA | 03/24/2026 | |||
| S-8 | Initial registration statement for secur... | Ars Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/09/2026 | |
| No record found. | |||||
| Load More | |||||
